Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy
Gloria Iacoboni, Josu Iraola‐Truchuelo, Alberto Mussetti, Paula Fernández‐Caldas, Victor Navarro Garcés, Ana África Martín López, Javier Delgado, Ariadna Pérez Martínez, Manuel Guerreiro, Ana Carolina Carolina Caballero Gonzalez, Núria Martínez‐Cibrián, Hugo Daniel Luzardo Henriquez, Jose M. Sánchez, Juan‐Manuel Sancho, Pere Barba, Mi Kwon, Lucía López‐Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Alejandro Martı́n, Mariana Bastos‐Oreiro, Pau Abrisqueta
Topics & Concepts
Chimeric antigen receptorLymphomaMedicineChemotherapySalvage therapyChemotherapy regimenAntigenOncologyCancer researchImmunologyImmunotherapyInternal medicineCancerCAR-T cell therapy researchLymphoma Diagnosis and Treatment